ArticleFrontiers in immunology2025

CXCR4 antagonism corrects neutrophil abnormalities and reduces pneumonia severity in a pharmacological mouse model of CXCR2 loss-of-function-mediated neutropenia.

Chi Huu Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.